Lexaria Bioscience (LEXXW) Competitors

$1.10

+0.10 (+10.00%)

(As of 07/3/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Trends

LEXXW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Lexaria Bioscience stock or one of its competitors? The main competitors of Lexaria Bioscience include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Lexaria Bioscience vs.

180 Life Sciences (NASDAQ:ATNFW) and Lexaria Bioscience (NASDAQ:LEXXW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, community ranking, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

: 180 Life Sciences and Lexaria Bioscience both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
180 Life Sciences N/A N/A
Lexaria Bioscience N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Lexaria Bioscience
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Company Net Margins Return on Equity Return on Assets
180 Life Sciences N/A N/A N/A
Lexaria Bioscience N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
180 Life Sciences N/A N/A N/A N/A N/A
Lexaria Bioscience $404.73K N/A N/A N/A N/A
: In the previous week, Lexaria Bioscience had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Lexaria Bioscience and 0 mentions for 180 Life Sciences. Lexaria Bioscience's average media sentiment score of 1.87 beat 180 Life Sciences' score of 1.28 indicating that 180 Life Sciences is being referred to more favorably in the media.
Company Overall Sentiment
180 Life Sciences Very Positive
Lexaria Bioscience Positive

Company	Underperform	Outperform
180 Life Sciences	N/A	N/A
Lexaria Bioscience	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Lexaria Bioscience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Net Margins	Return on Equity	Return on Assets
180 Life Sciences	N/A	N/A	N/A
Lexaria Bioscience	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
180 Life Sciences	N/A	N/A	N/A	N/A	N/A
Lexaria Bioscience	$404.73K	N/A	N/A	N/A	N/A

Company	Overall Sentiment
180 Life Sciences	Very Positive
Lexaria Bioscience	Positive

Summary

Lexaria Bioscience beats 180 Life Sciences on 2 of the 3 factors compared between the two stocks.

Ad Paradigm Press

Elon Musk: THIS will be bigger than Tesla

If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay.

See all the details you need here.

Get Lexaria Bioscience News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LEXXW vs. The Competition

Export to Excel

Metric	Lexaria Bioscience	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$137.28M	$5.09B	$8.61B
Dividend Yield	N/A	3.49%	2.84%	4.06%
P/E Ratio	N/A	249.10	167.45	18.16
Price / Sales	N/A	16,816.85	2,191.62	93.41
Price / Cash	N/A	12.08	32.28	28.81
Price / Book	N/A	6.67	4.69	4.25
Net Income	N/A	-$19.78M	$110.68M	$216.19M
7 Day Performance	29.40%	0.76%	-1.29%	0.27%
1 Month Performance	-28.10%	-1.80%	-2.03%	-2.15%
1 Year Performance	394.60%	9.36%	0.54%	-0.68%

Lexaria Bioscience Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars	$0.01 +10.9%	N/A	-15.8%	$0.00	N/A	4	Positive News
SXTPW 60 Degrees Pharmaceuticals	0 of 5 stars	$0.07 +0.1%	N/A	N/A	$0.00	$352,864.00	2	Positive News
DRTSW Alpha Tau Medical	0 of 5 stars	$0.23 +0.1%	N/A	-41.0%	$0.00	N/A	121	Positive News Gap Up
APLMW Apollomics	0 of 5 stars	$0.01 +40.0%	N/A	-83.5%	$0.00	N/A	59	News Coverage Positive News Gap Up
ARTLW Artelo Biosciences	0 of 5 stars	$0.01 +9.8%	N/A	-93.8%	$0.00	N/A	6	Positive News Gap Up High Trading Volume
BCDAW BioCardia	0 of 5 stars	$0.01 -11.8%	N/A	-97.9%	$0.00	$468,000.00	16	Positive News
BCTXW BriaCell Therapeutics	0 of 5 stars	$0.27 +1.9%	N/A	-91.7%	$0.00	N/A	16	Positive News Gap Down
CDIOW Cardio Diagnostics	0 of 5 stars	$0.04 +21.6%	N/A	-75.7%	$0.00	$32,993.00	7	Positive News Gap Down
CTCXW Carmell	0 of 5 stars	$0.07 -9.4%	N/A	N/A	$0.00	$3.73M	9	Positive News
SAVAW Cassava Sciences	0 of 5 stars	$0.03 -76.1%	N/A	N/A	$0.00	N/A	29	Gap Up High Trading Volume